Management of coccidioidomycosis in patients receiving biologic response modifiers or disease‐modifying antirheumatic drugs

Coccidioidomycosis (valley fever) is an endemic fungal infection of the American Southwest, an area with a large population of patients with rheumatic diseases. There are currently no guidelines for management of patients who develop coccidioidomycosis while under treatment with biologic response modifiers (BRMs) or disease‐modifying antirheumatic drugs (DMARDs). We conducted a retrospective study of how both concurrent diseases were managed and the patient outcomes at 2 centers in Tucson, Arizona.

[1]  G. Rutherford,et al.  The Public Health Impact of Coccidioidomycosis in Arizona and California , 2011, International journal of environmental research and public health.

[2]  N. Ampel.  The Complex Immunology of Human Coccidioidomycosis , 2007, Annals of the New York Academy of Sciences.

[3]  N. Ampel,et al.  Coccidioidomycosis as a Common Cause of Community-acquired Pneumonia , 2006, Emerging infectious diseases.

[4]  R. Laniado-Laborín,et al.  Coccidioidomycosis—A Fungal Disease of the Americas , 2005, PLoS medicine.

[5]  J. Bathon,et al.  Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases , 2004, Journal of intensive care medicine.

[6]  N. Ampel,et al.  Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. , 2004, Arthritis and rheumatism.

[7]  Suzanne M Johnson,et al.  In Vitro Whole-Blood Analysis of Cellular Immunity in Patients with Active Coccidioidomycosis by Using the Antigen Preparation T27K , 2002, Clinical and Vaccine Immunology.

[8]  J. Blair,et al.  Coccidioidomycosis in solid organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[10]  N. Ampel,et al.  Fungemia Due to Coccidioides immitis: AN ANALYSIS OF 16 EPISODES IN 15 PATIENTS AND A REVIEW OF THE LITERATURE , 1986, Medicine.

[11]  J. Wm,et al.  Fatal coccidioidomycosis in collagen vascular diseases. , 1983 .

[12]  J. Blair,et al.  Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. , 2009, Emerging infectious diseases.

[13]  M. Huppert.  Serology of coccidioidomycosis , 2005, Mycopathologia et mycologia applicata.

[14]  W. Johnson,et al.  Fatal coccidioidomycosis in collagen vascular diseases. , 1983, Journal of Rheumatology.